EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein

Poliane Silva Maciel iD, Gregório Guilherme Almeida, Gardênia Braz Figueiredo de Carvalho, Rosiane A da Silva-Pereira, Lis Ribeiro do Valle Antonelli, Cristina Toscano Fonseca iD

PLOS One · 08.12.2025 · 20 (12) · e0338310

DOI: 10.1371/journal.pone.0338310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.12.2025. Verfasst von Poliane Silva Maciel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitárias, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerai…. Hauptthemen laut MEDLINE: Schistosoma mansoni, Helminth Proteins, Fatty Acid-Binding Proteins, Antigens, Helminth. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior, Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico–Brasil, Fundação de Amparo a Pesquisa de Minas Gerais - Rede Mineira de Investigação em Mucosas e Pele.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many different Schistosoma antigens have been evaluated as vaccine candidates, including the recombinant form of the Schistosoma mansoni 14-kDa fatty acid-binding protein (rSm14). However, recombinant proteins often lack intrinsic immunostimulatory activity, a limitation that can be addressed by using vaccine formulations that contain adjuvants. In this work, we describe the immune response triggered by rSm14, a vaccine candidate against schistosomiasis currently under clinical trial, formulated with either (i) Monophosphoryl Lipid A (MPLA), (ii) MPLA/Alum, or (iii) Freund’s adjuvant. rSm14/MPLA and rSm14/MPLA/Alum formulations induced increased frequency of effector and memory CD4 + T and central memory CD8 + T cells, respectively. Both formulations induced significant production of rSm14-specific IgG and IgG1 antibodies, which could recognize the protein’s native form. The rSm14/Freund’s formulation elicited a robust immune response characterized by increased levels of IFN-γ, TNF, IgG, IgG1, and IgG2c antibodies, and expansion of memory B cell. These soluble factors have been implicated in the efficacy of Sm14-based vaccines. Despite inducing both humoral and cellular immune responses, the different formulations did not impact worm burden and the number of eggs trapped in the liver and intestine. Altogether, our findings indicate a limitation in the use of the molecules assessed in this study, such as IFN-γ, TNF, and specific antibodies, as correlates of protection and vaccine efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schistosoma mansoniHelminth ProteinsFatty Acid-Binding ProteinsAntigens, HelminthVaccinesSchistosomiasis mansoniAnimalsMiceImmunoglobulin GAntibodies, HelminthFemaleLipid AAdjuvants, ImmunologicRecombinant ProteinsFatty Acid Transport Proteins

Substanzen

Helminth ProteinsFatty Acid-Binding ProteinsAntigens, HelminthImmunoglobulin GAntibodies, HelminthVaccinesLipid Amonophosphoryl lipid ASM14 protein, Schistosoma mansoniAdjuvants, Immunologic

Autor:innen und Institutionen

  • Laboratório de Biologia e Imunologia de Doenças Infecciosas e Parasitárias, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.

ORCID-Profile: Poliane Silva Maciel, Cristina Toscano Fonseca

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior
  • Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico–Brasil
  • Fundação de Amparo a Pesquisa de Minas Gerais - Rede Mineira de Investigação em Mucosas e Pele
  • Fundação de Amparo a Pesquisa de Minas Gerais - Rede Mineira de  Imunobiológicos
  • Fundação de Amparo a Pesquisa de Minas Gerais - Rede De Pesquisa em Doenças Infecciosas Humanas e Animais do Estado de Minas
  • Fundação de Amparo a Pesquisa de Minas Gerais

Zitieren

APA

Maciel, P. S., Almeida, G. G., Carvalho, G. B. F., Silva-Pereira, R. A. D., Antonelli, L. R. D. V., & Fonseca, C. T. (2025). Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein. PLOS One, 20(12), e0338310. https://doi.org/10.1371/journal.pone.0338310

Vancouver

Maciel PS, Almeida GG, Carvalho GBF, Silva-Pereira RAD, Antonelli LRDV, Fonseca CT. Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein. PLOS One. 2025;20(12):e0338310. doi:10.1371/journal.pone.0338310

BibTeX
@article{Maciel2025,
  author = {Maciel, Poliane Silva and Almeida, Gregório Guilherme and Carvalho, Gardênia Braz Figueiredo de and Silva-Pereira, Rosiane A da and Antonelli, Lis Ribeiro do Valle and Fonseca, Cristina Toscano},
  title = {Exploring the immune responses triggered by vaccine formulations containing the recombinant Schistosoma mansoni 14kDa fatty acid-binding protein},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {12},
  pages = {e0338310},
  doi = {10.1371/journal.pone.0338310}
}
Kostenlos starten →